Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Revenue

Jagsonpal Pharmaceuticals had revenue of 963.71M INR in the quarter ending September 30, 2026, with 29.42% growth. This brings the company's total for the last twelve months to 3.16B, up 11.71% year-over-year. In the fiscal year ending March 31, 2026, Jagsonpal Pharmaceuticals had annual revenue of 2.87B with 6.89% growth. That makes Jagsonpal Pharmaceuticals the 30,626th largest company in the world by revenue and 2,180th in India.

• Revenue (ttm): 3.16B
• Revenue Growth: +11.71%
• P/S Ratio: 4.54
• Revenue / Employee: 2.43M
• Employees: 1,297
• Market Cap: 14.33B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 2.87B 99.9%
• Rest of The World 2.63M 0.1%

Fiscal year ended Mar 31, 2026 See the full Jagsonpal Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.87B	185.09M	6.89%
Mar 31, 2025	2.69B	600.14M	28.76%
Mar 31, 2024	2.09B	-280.12M	-11.83%
Mar 31, 2023	2.37B	191.30M	8.79%
Mar 31, 2022	2.18B	296.38M	15.77%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error